Mitsubishi UFJ Capital Co

Funding rounds backed by Mitsubishi UFJ Capital Co.

Export CSV
Funding disclosed in full
$31.6M
Median round
$15.8M
Rounds in calculation
2
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
CORE Biomedicine

Developing the next generation of precision medicines by going beyond genomics.

$21MSeries ABiotechUnited States
9 participantsCD CapitalElikon VentureInnoPinnacle FundMitsubishi UFJ Capital CoRoot Venture PartnersSuzhou Capital Group CoUTokyo Innovation Platform CoVision Incubate CoYuanBio Venture Capital
Rege Nephro Co

Developing innovative therapies and medical technologies for patients with kidney diseases who currently have limited treatment options

$10.6MSeries CBiotechJapan
13 participantsArcus South East AsiaBA7 Venture Capital CORPChushin Venture Capital CoDCI Partners CoJAFCO Group CoJIC Venture Growth Investments CoKyoshin Social Capital CoKyoto University Innovation Capital CoMitsubishi UFJ Capital CoRAP-HI CoSPARX Asset Management CoTaiAn Technologies CorpTOHO HOLDINGS CO